eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Remicade, Methylprednisolone for a Female patient aged 37

This is a personalized study for a 37 year old female patient. The study is created by eHealthMe based on reports of 1,136 people who take the same drugs and have drug interactionsfrom FDA.

On Dec, 9, 2014: 1,136 people who reported to have interactions when taking Remicade, Methylprednisolone are studied

Trend of Remicade, Methylprednisolone's drug interactions, side effects, and effectiveness reports (2257467)

Information of the patient in this study:

Age: 37

Gender: female

Drugs taking:
- Remicade
- Methylprednisolone

Drug interactions have: Antinuclear Factor Positive, Autoimmune Hepatitis, Cholestasis, Coagulation Disorder Nos, Hepatic Encephalopathy, Jaundice Nos, Urinary Tract Infection Nos

eHealthMe real world results:

Comparison with this patient's adverse outcomes among females aged 37 (±5):

InteractionNumber of reports
Antinuclear Factor Positive4 (4.44%)
Autoimmune Hepatitis8 (8.89%)
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)6 (6.67%)
Coagulation Disorder Nos6 (6.67%)
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)6 (6.67%)
Jaundice Nos2 (2.22%)
Urinary Tract Infection Nos6 (6.67%)

Most common interactions experienced by females aged 37 (±5) in the use of Remicade, Methylprednisolone:

InteractionNumber of reports
Infusion Related Reaction30
Pyrexia (fever)26
Arthralgia (joint pain)24
Rash (redness)22
Nausea (feeling of having an urge to vomit)18
Dyspnoea (difficult or laboured respiration)17
Headache (pain in head)16
Pruritus (severe itching of the skin)16
Pharyngolaryngeal Pain12
Flushing (the warm, red condition of human skin)12

Most common interactions experienced by females aged 37 (±5) in long term use of Remicade, Methylprednisolone:

InteractionNumber of reports
Drug Interaction3
B-cell Lymphoma (blood cancer affecting b cells)2
B-cell Unclassifiable Lymphoma High Grade (rapidly progressing unclassifiable b-cell cancer difficult to treat- high grade)2
Thymus Disorder (disease of thymus)2
Non-hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system)2
Thymoma Malignant (a cancerous tumour originating from the epithelial cells of the thymus)2

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Antinuclear Factor Positive4 (0.35%)
Autoimmune Hepatitis10 (0.88%)
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)22 (1.94%)
Coagulation Disorder Nos8 (0.70%)
Hepatic Encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)8 (0.70%)
Jaundice Nos6 (0.53%)
Urinary Tract Infection Nos36 (3.17%)

Most common interactions experienced by people in the use of Remicade, Methylprednisolone:

InteractionNumber of reports
Infusion Related Reaction384
Dyspnoea (difficult or laboured respiration)250
Pyrexia (fever)232
Flushing (the warm, red condition of human skin)144
Chest Pain126
Nausea (feeling of having an urge to vomit)126
Arthralgia (joint pain)118
Headache (pain in head)107
Drug Ineffective92
Malaise (a feeling of general discomfort or uneasiness)86

Most common interactions experienced by people in long term use of Remicade, Methylprednisolone:

InteractionNumber of reports
Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)8
Memory Impairment6
Platelet Count Decreased6
Lupus-like Syndrome (a disease symptom matches with lupus an immune disease)4
Flushing (the warm, red condition of human skin)4
Rheumatoid Nodule (a local swelling or tissue lump with rheumatoid disease)4
Rash (redness)4
Dizziness4
Drug Interaction4
Supraventricular Tachycardia (rapid heart rhythm originating at or above the atrioventricular node)4

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.